{"created":"2023-06-19T11:23:38.937704+00:00","id":4218,"links":{},"metadata":{"_buckets":{"deposit":"912c91fb-50d2-40af-8d5e-a56d32387b41"},"_deposit":{"created_by":3,"id":"4218","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"4218"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00004218","sets":["7","7:23"]},"author_link":["12930","12931"],"item_5_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2008-11-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"11","bibliographicPageEnd":"1844","bibliographicPageStart":"1838","bibliographicVolumeNumber":"57","bibliographic_titles":[{"bibliographic_title":"新薬と臨床"}]}]},"item_5_description_33":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"モキシフロキサシン塩酸塩(MFLX)の各種感染性皮膚疾患に対する有効性を検討した。対象は感染性皮膚疾患に対して使用した第一選択薬が効果不十分のため本薬を1日1回、7日間連続投与した24症例で、その対象疾患、創部培養結果、併用療法、前投与薬剤、皮膚改善度及び副作用を調査した。その結果、対象疾患は感染性粉瘤5例、蜂窩織炎4例、丹毒4例、縫合創二次感染3例などで、創部ぬぐい液培養をした6例中4例で以下の起炎菌を同定した。Corynebacterium striatum、Enterococcus faecalis、Pseudomonas aeruginosa、MRSA.併用療法は5例で切開・排膿を認め、前投与薬剤はセフェム剤19例、テトラサイクリン剤4例、マクロライド剤1例で、症状改善度はやや改善以上が90%、改善以上でも85%と高い有効率であった。また、副作用はめまい、嘔気、掻痒が各1例であった。","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_5_description_36":{"attribute_name":"注記","attribute_value_mlt":[{"subitem_description":"雑誌掲載版","subitem_description_type":"Other"}]},"item_5_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_5_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_5_source_id_22":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0559-8672","subitem_source_identifier_type":"PISSN"}]},"item_5_text_44":{"attribute_name":"ID(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"2009122266"}]},"item_5_text_54":{"attribute_name":"閲覧数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"773"}]},"item_5_text_55":{"attribute_name":"ダウンロード数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"315"}]},"item_5_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Iizuka, Hajime"},{"subitem_text_language":"en"}]},"item_5_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"本間, 大","creatorNameLang":"ja"},{"creatorName":"ホンマ, マサル","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"12930","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"飯塚, 一","creatorNameLang":"ja"},{"creatorName":"イイヅカ, ハジメ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"12931","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"4947.pdf","filesize":[{"value":"3.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"4947.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/4218/files/4947.pdf"},"version_id":"94af6b47-8e0f-4d2c-80ea-bc9b2f63d303"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"モキシフロキサシン塩酸塩錠(アベロックス400mg錠)の各種感染性皮膚疾患に対する有効性の検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"モキシフロキサシン塩酸塩錠(アベロックス400mg錠)の各種感染性皮膚疾患に対する有効性の検討","subitem_title_language":"ja"}]},"item_type_id":"5","owner":"3","path":["6","7","23"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2012-11-27"},"publish_date":"2012-11-27","publish_status":"0","recid":"4218","relation_version_is_last":true,"title":["モキシフロキサシン塩酸塩錠(アベロックス400mg錠)の各種感染性皮膚疾患に対する有効性の検討"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-07-26T08:50:51.577004+00:00"}